W. Blake Coblentz joined the firm's Intellectual Property Practice Group in 2012 as a member in the Washington, D.C., office. Blake concentrates his practice in complex patent cases for clients in the biotechnology and pharmaceutical industries.
Blake is a registered patent attorney and focuses his practice on the representation of generic pharmaceutical companies in the areas of Paragraph IV design strategies, Hatch-Waxman litigation, and biosimilar market opportunities. Most of his intellectual property experience has been in areas of pharmaceuticals, therapeutic methods, biochemistry, molecular and cellular biology, gene synthesis, recombinant DNA technology, immunology, diagnostic assays and vaccines. His practice also includes representing clients in interferences before the USPTO; preparing patentability, infringement and invalidity opinions; representing clients in post grant proceedings; and preparing and prosecuting U.S. and foreign patent applications.
Blake graduated from DePaul University College of Law. He earned his master's degree in molecular cell biology from Washington University in St. Louis and his bachelor's degree in biology, cum laude, from Birmingham-Southern College.